Choose a section
A new vaccine against pneumococcal disease appears as safe as an older one, according to a new study.
Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.
Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.
A subsidiary of drug maker Mylan is sponsoring a campaign to draw attention to severe allergic reactions.
Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.
Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.
Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company announced.
A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.
Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.
A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.